New combo therapy may boost bone strength in older women
NCT ID NCT05884372
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding eldecalcitol (a vitamin D-like drug) to denosumab (a bone-strengthening shot) works better than denosumab with regular vitamin D for postmenopausal women with weak bones (osteoporosis). About 100 women took part for 12 months. The main goal was to see if the combination improved bone density more. This is a disease-control study because osteoporosis requires ongoing management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zeng,Yuhong
Xi'an, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Could a common diabetes drug weaken your bones?
- A tastier calcium chew might boost bone Health—But does it work?
- Exercise program aims to steady the stance of osteoporosis patients
- Can a Bone-Strengthening infusion given right after hip surgery prevent a second break?
- Can a single dose of zoledronic acid safely treat bone loss in dialysis patients?